Position in ZBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,109,298
+$23,455,367 QoQ
Shares Held
4,023,219
0.0% QoQ
Ownership
6.17%
of shares outstanding
% of Portfolio
6.43%
of 13F equity value
Holder Rank
#3
of 145 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NEA Management Company, LLC holds $1,505,317,406 across 24 Biotechnology names. ZBIO ranks #7 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $246,594,552 | |
| 2 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $199,519,627 | |
| 3 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $186,153,611 | |
| 4 | CELC |
Celcuity Inc.
|
1,710,561 | $178,958,891 | |
| 5 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $164,552,620 | |
| 6 | SVRA |
Savara Inc
|
24,471,264 | $150,742,986 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
This page
|
4,023,219 | $102,109,298 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
3,969,834 | $67,368,082 |
All Filings in ZBIO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,109,298 | 4,023,219 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $78,653,931 | 4,023,219 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $127,928,081 | 3,523,219 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $60,688,561 | 2,733,719 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,489,737 | 2,733,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,650,189 | 2,613,948 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $21,408,234 | 2,613,948 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $44,228,000 | 2,613,948 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||